Fajardo, Rudy A.

HRN: 08-37-01  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/18/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/18/2024
08/25/2024
IV
4.5 G
Every 8 Hours
S/P Ex Lap
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: